MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$31,159K
Free Cash flow
-$63,205K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of short-term investm...
Accrued expenses and other curre...
Share-based compensation expense
Others
Negative Cash Flow Breakdown
Net loss
Purchases of short-term investme...
Contract liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
-
-
67,482
-
Total operating expenses
-
-
371,113
-
Interest and other income, net
-
-
26,774
-
Interest expense
-
-
1,512
-
Income tax expense
-
-
297
-
Net loss
-68,327
-73,333
-80,999
-74,116
Share-based compensation expense
8,209
8,416
11,352
10,965
Amortization of premium and accretion of discounts on short-term investments, net
741
900
1,382
1,924
Depreciation expense
369
355
403
164
Non-cash interest expense
111
106
103
141
Accounts receivable, net
98
544
6,744
-
Receivable from contracts with collaborators
-
-
-
31,362
Inventory
1,642
430
413
-
Prepaid expenses and other current assets
-4,339
562
-2,890
10,289
Operating lease right-of-use and other long-term assets
-336
-689
558
2,883
Accounts payable
-4,650
2,026
4,499
-
Accrued expenses and other current liabilities
9,659
-16,216
12,654
-
Accounts payable and accrued expenses
-
-
-
12,716
Operating lease liabilities
141
3,778
-
-
Other long-term liabilities
109
204
118
297
Contract liabilities
-10,364
-9,443
156,288
15,664
Net cash used in operating activities
-62,549
-85,854
117,273
-80,627
Maturities of short-term investments
112,500
147,498
177,500
235,032
Purchases of short-term investments
19,635
171,601
239,775
138,499
Purchases of property and equipment
656
128
2,321
2,567
Net cash provided by (used in) investing activities
92,209
-24,231
-64,596
93,966
Proceeds from issuance of stock under equity plans
1,499
69
1,135
0
Proceeds from issuances of common stock and pre-funded warrants, net of offering costs
-
-
0
-
Net cash provided by financing activities
1,499
69
1,135
0
Net decrease in cash and cash equivalents
31,159
-110,016
53,812
13,339
Cash and cash equivalents at beginning of period
39,083
149,099
95,287
224,462
Cash and cash equivalents at end of period
70,242
39,083
149,099
95,287
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Maturities of short-term
investments
$112,500K
(-67.16%↓ Y/Y)
Proceeds from issuance of
stock under equity...
$1,499K
(127.81%↑ Y/Y)
Net cash provided by
(used in) investing...
$92,209K
(317.13%↑ Y/Y)
Net cash provided by
financing activities
$1,499K
(127.81%↑ Y/Y)
Canceled cashflow
$20,291K
Net decrease in cash
and cash...
$31,159K
(121.86%↑ Y/Y)
Canceled cashflow
$62,549K
Purchases of short-term
investments
$19,635K
(-94.88%↓ Y/Y)
Purchases of property and
equipment
$656K
(-62.51%↓ Y/Y)
Accrued expenses and
other current...
$9,659K
Share-based compensation
expense
$8,209K
(-44.50%↓ Y/Y)
Prepaid expenses and
other current assets
-$4,339K
(-150.74%↓ Y/Y)
Depreciation expense
$369K
(-20.65%↓ Y/Y)
Operating lease
right-of-use and other...
-$336K
(-111.50%↓ Y/Y)
Operating lease
liabilities
$141K
Non-cash interest
expense
$111K
(-59.04%↓ Y/Y)
Other long-term
liabilities
$109K
(-82.64%↓ Y/Y)
Net cash used in
operating activities
-$62,549K
(37.89%↑ Y/Y)
Canceled cashflow
$23,273K
Net loss
-$68,327K
(44.70%↑ Y/Y)
Contract liabilities
-$10,364K
(-143.61%↓ Y/Y)
Accounts payable
-$4,650K
Inventory
$1,642K
Amortization of premium and
accretion of discounts on...
$741K
(-85.70%↓ Y/Y)
Accounts receivable, net
$98K
Buy us a coffee
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA)